Objective To study the efficacy and toxicity of tetrakis(hydroxymethyl)phosphonium sulfate(THPS)in indoor air disinfection.Methods The orthogonal experiments were employed with three factors including concentration of THPS,temperature and time,and four levels including the concentrations of THPS,0.05%,0.1%,0.5%,1%,and the temperature,15℃,20℃,25℃,30℃,and the time,2 h,4 h,8 h,16 h.The germicidal effect of THPS with those factors was assessed.Using modified method,Daphnia magna straus(Cladocera crustacea),Brachydanio rerio,mice were randomly divided into 5 dose groups and a control respectively.For Daphnia magna straus(Cladocera crustacea),123.03 mg/L,134.90 mg/L,147.91 mg/L,162.18 mg/L and 177.83 mg/L,for Brachydanio rerio,42.66 mg/L,57.54 mg/L,77.62 mg/L,104.71 mg/L and 140.90 mg/L,for mice,183.60 mg/kg,293.75 mg/kg,470.00 mg/kg,752.00 mg/kg and 1 203.20 mg/kg.The data for 2th,4th and 7th day of treatment were collected for calculation of the 48h-EC50,the 96h-LC50 and the acute oral LD50 in Daphnia magna straus(Cladocera crustacea),Brachydanio rerio and mice.Results The maximal germicidal rate of THPS in indoor air was over 86%.At the concentration of 0.5% THPS,4 h reaction time,germicidal efficacy of THPS was optimal.The toxicity test indicated that the acute oral LD50 for mice was 492.72 mg/kg,the 48 h-EC50 for Daphnia magna straus(Cladocera crustacea)was 143.61 mg/L,the 96h-LC50 for Brachydanio rerio was 84.17mg/L.Conclusion The toxicity of THPS is low and can be used for indoor air disinfection with a good efficacy and the potential benefit for environment.

Objective To study the feasibility and rehabilitation outcomes of one -stage cochlear implantation (CI) in profound deaf children with secretory otitis media (SOM ) .Methods A total of 11 profound deaf children with soal receired one -soage unilateral cochlear implantation with a follow -up period from 13~60 months .In-flamed mucosa in the mastoid as well as exudates were removed radical1y at the time of implantation for adequate drainage of the middle ear .After the sugery ,the patients were followed up and the hearing and rehabilitating out-comes were eveluated .Results All 11 patients were successfully operated with 8 cases in the right ear and 3 cases in the left ear .Among them ,7 cases were nucleus 24 CA ,1 case losa clarion AB 90 K ,2 cases were medel combi 40+and 1 case was pulsar .All patients were successfully operated .No infectious complications occurred .No recurrence of secretory otitis media was observed .After initial stimulation and post regular fitting ,the status of the implant-able devices were all stable .All the implantees had satisfied hearing and entered normal kindergartens or schools . Conclusion Profound deaf pediatric patients with SOM are not an absolute contraindication for CI .With sufticient pre-operation preparontion ,proper trentment and nursing .Cochlear implantation should be condnote as early as possible better rehabilitation performance .

Objective: To investigate the frequency of KRAS mutation in mucinous epithelial lesions of the endometrium, and analyze the correlation between KRAS mutation and the clinicopathologic features. Methods: The cohort included forty-three cases of mucinous epithelial lesions of the endometrium selected from July 2015 to October 2017 from Beijing Obstetrics and Gynecology Hospital, and 22 control cases. Genomic DNA was extracted from formalin-fixed paraffin-embedded tissue sections. Polymerase chain reaction amplification for KRAS exons 2 and 3 was performed, followed by sequencing using capillary electrophoresis. The Fisher exact test was used to compare the prevalence of KRAS mutation among the different groups. Results: The patients′age ranged from 33 to 77 years [mean (55.12±9.34) years, median 55 years]. None of the eight cases of endometrial hyperplasia with mucinous differentiation without atypia showed KRAS mutation. The frequency of KRAS mutations was 1/10 in endometrial atypical hyperplasia, 1/12 in endometrioid carcinoma, 4/11 in endometrial atypical hyperplasia with mucinous differentiation (EAHMD), 6/15 in endometrioid carcinoma with mucinous differentiation (ECMD) and 8/9 in mucinous carcinoma (MC), respectively. The differences were statistically significant between MC versus EC (P<0.01) and MC versus ECMD (P<0.05). Conclusion The high frequency of KRAS mutation in EAHMD, ECMD and MC indicates that KRAS mutational activation is implicated in the pathogenesis of endometrial mucinous carcinoma.